Advertisement

Persistence of Echovirus Type 6 in Cultured Cells

  • V. F. Righthand
Conference paper

Abstract

Human enteroviruses cause a wide spectrum of systemic infections including myocarditis and encephalitis. Although these viruses are usually cytocidal and cause self-limiting infections, the enteroviruses can also establish persistent infections which result in chronic disease syndromes [3, 7, 9, 11, 14, 17–19]. Recent experiments by Kandolf [7] suggest that chronic dilated cardiomyopathies are associated with persistence of a variety of different enteroviruses, including echovirusese In my laboratory, we have utilized in vitro models to study the cellular and molecular aspects of acute and chronic infections by the human enterovirus, echovirus type 6. The purpose of these studies is to investigate the mechanisms responsible for the stability and duration of viruses during either acute or chronic infections. The ultimate goal of these studies is to develop an approach for the prevention and/or treatment of acute and chronic enterovirus infections including viral heart disease.

Keywords

Virus Particle Human Enterovirus Human Lymphoid Cell Lytic Virus Purify Virus Preparation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Carp RI (1981) Persistent infections of human lymphoid cells with poliovirus and development of temperature-sensitive mutants. Intervirology 15: 49–56PubMedCrossRefGoogle Scholar
  2. 2.
    Crowell RL, Syverton JT (1961) The mammalian cell-virus relationship. VI. Sustained infection of HeLa cells by coxsackie B3 virus and effect on superinfection. J Exp Med 113: 419–435PubMedCrossRefGoogle Scholar
  3. 3.
    Davis LE, Bodian D, Price D, Butler IJ, Vickers JH (1977) Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. N Engl J Med 297: 241–245PubMedCrossRefGoogle Scholar
  4. 4.
    Gibson JP, Righthand VF (1985) Persistence of echovirus 6 in cloned human cells. J Virol 54: 219–223PubMedGoogle Scholar
  5. 5.
    Holland JJ, Spindler K, Horodyski F, Grabau E, Nichol S, Vande Pol S (1982) Rapid evolution of RNA genomes. Science 215: 1577–1585PubMedCrossRefGoogle Scholar
  6. 6.
    Jacobson M, Baltimore D (1958) Morphogenesis of poliovirus 1. Association of the viral RNA with the coat protein. J Mol Biol 33: 369–378CrossRefGoogle Scholar
  7. 7.
    Kandolf R (1988) The impact of recombinant DNA technology on the study of enteroviral heart disease. In: Friedman H, Bendinelli M (eds) Coxsackieviruses — a general update. Plenum, New YorkGoogle Scholar
  8. 8.
    Kandolf R, Canu A, Hofschneider PH (1985) Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. J Mol Cell Cardiol 17: 167–181PubMedCrossRefGoogle Scholar
  9. 9.
    Kew OM, Nottay BK, Hatch MH, Nakano JH, Obijeski JF (1981) Multiple genetic changes can occur in the oral poliovaccines upon replication in humans. J Gen Virol 56: 337–347PubMedCrossRefGoogle Scholar
  10. 10.
    Matteucci D, Paglianti M, Giangregori AM, Capobianchi MR, Dianzani F, Bendinelli M (1985) Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines. J Virol 56: 651–654PubMedGoogle Scholar
  11. 11.
    Miller JR (1981) Prolonged intracerebral infection with poliovirus in asymptomatic mice. Ann Neurol 9: 590–596PubMedCrossRefGoogle Scholar
  12. 12.
    Pacsa S (1961) Poliovirus-carrying lines of HeLa cells: their establishment and sensitivity to virus. Acta Microbiol Acad Sci Hung 8: 329–332PubMedGoogle Scholar
  13. 13.
    Puck TT, Marcus PI (1955) A rapid method for viable cell titration and clone production with HeLa cells in tissue culture: the use of X-irradiated cells to supply conditioning factors. Proc Natl Acad Sci USA 41: 432–437PubMedCrossRefGoogle Scholar
  14. 14.
    Rozhon EJ, Wilson AK, Jubelt B (1984) Characterization of genetic changes occurring in attenuated poliovirus 2 during persistent infection in mouse central nervous systems. J Virol 50: 137–144PubMedGoogle Scholar
  15. 15.
    Takemoto KK, Habel K (1959) Virus-cell relationship in a carrier culture of HeLa cells and coxsackie A9 virus. Virology 7: 28–44PubMedCrossRefGoogle Scholar
  16. 16.
    Vogt M, Dulbecco R (1958) Properties of a HeLa cell culture with increased resistance to poliomyelitis. Virology 5: 425–434PubMedCrossRefGoogle Scholar
  17. 17.
    Wilfert CM, Buckley RH, Mohanakamur T, Griffin JF, Katz SL, Whisnant JK, Eggleston PA, Moore M, Treadwell E, Oxman MN, Rosen FS (1977) Persistent and fatal nervous system ECHO virus infection in patients with agammaglobulinemia. N Engl J Med 296: 1485–1489PubMedCrossRefGoogle Scholar
  18. 18.
    Wyatt HV (1973) Poliomyelitis in hypogammaglobulinemics. J Infect Dis 128: 802–806PubMedCrossRefGoogle Scholar
  19. 19.
    Yoneyama T, Hagiawara A, Hara M, Shimojo H (1982) Alteration in oligonucleotide fingerprint patterns of the viral genome in poliovirus type 2 isolated from paralytic patients. Infect Immun 37: 46–53PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • V. F. Righthand
    • 1
  1. 1.Department of Immunology and Microbiology, School of MedicineWayne State UniversityDetroitUSA

Personalised recommendations